ArticleBMC public health2026
Strengthening tobacco control enforcement in Nigeria: a policy and regulatory analysis supporting an expanded mandate for NAFDAC.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNigeria has adopted comprehensive tobacco control legislation, including the National Tobacco Control Act (NTCA) 2015 and Tobacco Control Regulations 2019, yet continues to experience high tobacco-related morbidity and a substantial illicit cigarette market. Institutional fragmentation and weak enforcement capacity, compounded by evolving obligations under the WHO Framework Convention on Tobacco Control (FCTC) and the Protocol to Eliminate Illicit Trade in Tobacco Products, undermine effective implementation.
methodsA desk-based qualitative policy and regulatory analysis was conducted using three complementary approaches: (1) comparative legal mapping of Nigeria’s tobacco control framework against core WHO FCTC and Illicit Trade Protocol obligations; (2) thematic synthesis of WHO guidance, treaty decisions, and peer-reviewed evidence on institutional arrangements for tobacco regulation; and (3) an implementation-readiness assessment of the National Agency for Food and Drug Administration and Control (NAFDAC) across key capacity domains.
resultsThe analysis identified five interrelated structural gaps: fragmented institutional authority; absence of a central product regulator; weak supply-chain and illicit trade control; inadequate protection from tobacco industry interference; and a regulatory vacuum for emerging nicotine products. Nigeria’s current ministry-led configuration constrains compliance with WHO FCTC Articles 9, 10, 11, and 15, while NAFDAC already possesses significant laboratory, port-of-entry, and digital traceability capacity developed through pharmaceutical regulation.
conclusionReconfiguring Nigeria’s tobacco control architecture to assign NAFDAC a central technical regulatory mandate, while retaining health policy stewardship within the Federal Ministry of Health (FMoH), offers a legally feasible and context-appropriate pathway to strengthen enforcement, meet evolving treaty expectations, and reduce tobacco-related harms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.